age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67.01398
|
female
| 0
| 32
|
Lung Cancer
|
Cancer
| 1
| 10
|
under $11k
| 0
| null | null | null | 6.25
|
white
| 16.398438
| 9
| 0.714966
| 0.434998
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 32
| 96
| 9.298828
| 52
| 20
| 37
| null | null | 0.399963
| 0.799927
| 138
| null | null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,940
| 0
|
80.44098
|
male
| 1
| 70
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 221,947.625
| 148,211
| null | 47
|
white
| 31
| 57
| 0.521973
| 0.405945
| 7
| 0
| 0
|
no
| 0.7
| 0.65
|
dnr after sadm
| 69
| 58
| 14.599609
| 154
| 10
| 38.59375
| 135
| 2
| 3.299805
| 1
| 132
| 7.399414
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 70
| 1
|
46.45898
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$25-$50k
| 0
| 87,008.125
| 59,460.2812
| null | 23
|
white
| 34.898438
| 65
| 0.675903
| 0.581909
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 33
| 45
| 25.199219
| 124
| 28
| 39
| 206.65625
| 3.799805
| 2.199707
| 1.399902
| 140
| 7.5
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,939
| 0
|
64.04095
|
female
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 12,177
| null | null | 13.5
|
white
| 29
| 43
| 0.504883
| 0.387939
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.3
|
no dnr
| 13
| 107
| 0.699951
| 100
| 29
| 37.09375
| 371.375
| null | 0.5
| 0.599976
| 132
| 7.469727
| null | null | null | 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 75
| 1
|
63.211
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 8,286.344
| 6,482.3594
| null | 11.5
|
white
| 14.599609
| 15
| 0.911987
| 0.850952
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 70
| 8
| 80
| 20
| 36.39844
| 428.5625
| null | 1.5
| 1.099854
| 142
| 7.459961
| null | null | null | null | null | null | 2.336914
| 1,132
| 1
|
44.909
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 45,405.188
| 28,532.3281
| null | 50
|
black
| 32.898438
| 57
| 0.709961
| 0.621948
| 3
| 1
| 0
|
no
| 0.25
| 0.25
|
no dnr
| 5
| 112
| 21.796875
| 146
| 55
| 39
| 94
| 2.099609
| 0.199982
| 0.799927
| 142
| 7.349609
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
38.784
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 8,524.148
| 5,521.2148
| null | 12
|
white
| 22.199219
| 10
| 0.66394
| 0.362976
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 103
| 23.097656
| 90
| 20
| 36.5
| null | 3
| 0.299988
| 0.899902
| 139
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.14209
| 38
| 1
|
45.00497
|
male
| 0
| 97
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 100
| 177,418.375
| 120,515.938
| null | 32.75
|
white
| 21.898438
| 32
| 0.387939
| 0.313965
| 6
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 4
| 130
| 19.597656
| 130
| 10
| 38.69531
| 246.65625
| null | null | 1
| 140
| 7.539062
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 142
| 1
|
65.91595
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 1
|
under $11k
| 0
| null | null | null | 6.5
|
black
| 16
| 15
| 0.724976
| 0.450989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 73
| 6.199219
| 90
| 18
| 36.5
| null | null | null | 0.799927
| 135
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 41
| 1
|
49.89697
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 37
| 36,192.281
| 24,370.8906
| null | 44.5
|
white
| 28
| 46
| 0.631958
| 0.529907
| 5
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 7
| 73
| 0.299988
| 116
| 33
| 37.79688
| 225
| null | 0.399963
| 1.199951
| 135
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
55.28799
|
female
| 1
| 25
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 7
|
$11-$25k
| 9
| null | null | null | 21.25
|
white
| 23.898438
| 31
| 0.727905
| 0.574951
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 25
| 84
| 6.099609
| 110
| 24
| 36.89844
| null | 3.199707
| 6.699219
| 1.399902
| 140
| 7.469727
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 25
| 1
|
33.254
|
male
| 1
| 61
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 123,138.188
| 84,588.25
| null | 21.25
|
black
| 43.695313
| 96
| 0.085999
| 0.032997
| 31
| 0
| 0
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 61
| 69
| 0.399963
| 145
| 52
| 39.39844
| 373.3125
| 2
| 16.296875
| 1.699951
| 148
| 7.509766
| null | null | null | 0
| 0
| null | 0
| 61
| 1
|
45.97098
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 34,001.469
| 24,492.7812
| null | 27
|
white
| 31.597656
| 21
| 0.778931
| 0.645996
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 16
| 80
| 14.398438
| 114
| 26
| 36.79688
| 283.3125
| 2.799805
| 1.399902
| 1
| 125
| 7.369141
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,934
| 0
|
79.81897
|
male
| 1
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 44
| 89,738.938
| 61,880.625
| null | 41
|
white
| 36.796875
| 73
| 0.051994
| 0.016998
| 24
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 7
| 63
| 0.399963
| 112
| 10
| 37.19531
| 131.65625
| null | 0.599976
| 9.199219
| 134
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 3.064453
| 17
| 1
|
75.30194
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 61
| 23,312.641
| 15,998.5312
| null | 39
| null | 78.09375
| 81
| 0
| 0
| 7
| 0
| 0
|
yes
| 0.4
| 0.4
|
dnr after sadm
| 3
| 0
| 58.59375
| 0
| 0
| 39.59375
| 137.75
| 2.5
| 0.899902
| 1.699951
| 149
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 1.544189
| 3
| 1
|
60.30399
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| null | null | null | 18
|
black
| 22.097656
| 18
| 0.747925
| 0.487
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 9
| 93
| 4.899414
| 112
| 28
| 39.79688
| null | null | 0.699951
| 0.699951
| 133
| null | null | null | null | 2
| 0
|
<2 mo. follow-up
| 0
| 40
| 1
|
59.62198
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| null | null | 0
| 14,459.148
| 9,915.3906
| null | 21
|
white
| 20.097656
| 19
| 0.875977
| 0.792969
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 5
| 97
| 10.298828
| 110
| 24
| 36.39844
| 210
| null | null | 1
| 137
| 7.449219
| null | null | null | null | null | null | 2.17041
| 1,933
| 0
|
43.159
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 13,811
| null | null | 6
|
black
| 14.699219
| 11
| 0.941895
| 0.900879
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 77
| 4.299805
| 90
| 18
| 36.89844
| null | null | 0.799927
| 0.799927
| 138
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.215332
| 701
| 1
|
68.19196
|
male
| 1
| 20
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 9
|
under $11k
| 0
| 69,824.688
| 46,296.5
| null | 28.333328
|
white
| 25.699219
| 29
| 0.707886
| 0.547974
| 11
| 1
| 0
|
no
| 0.4
| 0.4
|
dnr after sadm
| 7
| 83
| 13.398438
| 98
| 8
| 35.89844
| 156
| null | null | 1.299805
| 152
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 20
| 1
|
77.98798
|
female
| 0
| 23
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| null | null | null | 26
|
white
| 17.898438
| 18
| 0.824951
| 0.713989
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 23
| 113
| 15.199219
| 82
| 25
| 37.59375
| 303.3125
| 3.599609
| 0.299988
| 0.399963
| 137
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 180
| 1
|
68.99396
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 9
| 53,060.125
| 36,860.4375
| null | 26.333328
|
black
| 19.796875
| 32
| 0.816895
| 0.754883
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 23
| 118
| 7.199219
| 150
| 20
| 38.59375
| 206.65625
| 2.899902
| null | 0.799927
| 138
| 7.519531
| null | null | null | null | null | null | 1.861084
| 1,659
| 1
|
50.40097
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 4,376.5
| 3,473.1387
| null | 5.5
|
other
| 18.199219
| 23
| 0.718994
| 0.441956
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 7
| 83
| 2.699707
| 52
| 24
| 37.5
| null | null | 0.699951
| 1.5
| 133
| null | null | null | null | null | 5
| null | 5
| 1,931
| 0
|
77.10596
|
male
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 28,218.141
| 19,108.8438
| null | 28.5
|
white
| 19.597656
| 27
| 0.720947
| 0.634888
| 5
| 0
| 0
|
yes
| 0.75
| 0.5
|
dnr after sadm
| 5
| 103
| 10.798828
| 112
| 9
| 37.59375
| 213.3125
| 2.399902
| 0.399963
| 0.799927
| 143
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 1.948975
| 11
| 1
|
80.13397
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
$25-$50k
| 0
| 67,287.125
| 45,010.0625
| null | 42.666657
|
white
| 32.296875
| 59
| 0.56897
| 0.45697
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 2
| 59
| 10.5
| 94
| 12
| 38
| 85
| null | 1
| 2.399902
| 130
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
71.05298
|
female
| 0
| 71
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 73,721.125
| 52,616.9062
| null | 15.25
|
white
| 16.5
| 17
| 0.873901
| 0.789917
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 71
| 103
| 26
| 98
| 18
| 36.09375
| 385.6875
| 4
| 0.599976
| 0.899902
| 142
| 7.489258
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 183
| 1
|
65.073
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 8,162.348
| 6,030.125
| null | 11.5
|
white
| 19.597656
| 34
| 0.835938
| 0.731934
| 1
| 0
| 0
|
yes
| 0.9
| 0.75
|
no dnr
| 10
| 90
| 20.199219
| 75
| 26
| 35.79688
| 214.28125
| null | 0.699951
| 1
| 137
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,910
| 1
|
39.43597
|
male
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 111,050.375
| 72,371.5625
| null | 41.25
|
white
| 24.5
| 55
| 0.850952
| 0.799927
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 21
| 59
| 16.898438
| 115
| 60
| 38.29688
| 226.65625
| null | 0.599976
| 1.099854
| 133
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 1.862793
| 25
| 1
|
77.02698
|
male
| 1
| 85
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 15
|
$25-$50k
| 9
| 86,263
| 63,587.5625
| null | 16.5
|
white
| 23
| 41
| 0.625
| 0.439941
| 9
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 6
| 67
| 20.699219
| 135
| 31
| 38.39844
| 211.40625
| null | 0.299988
| 1.5
| 140
| 7.40918
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 85
| 1
|
37.41498
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 140,070.375
| 98,097.8125
| null | 15
|
black
| 26.398438
| 36
| 0.79895
| 0.731934
| 46
| 1
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 14
| 111
| 19.097656
| 98
| 16
| 35.5
| 268
| 2.799805
| 0.299988
| 5
| 138
| 7.40918
| null | null | null | null | null | null | 2.78125
| 1,927
| 0
|
48.84299
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
$25-$50k
| 0
| 55,942.812
| 36,934.5
| null | 26.666656
|
black
| 25.699219
| 30
| 0.814941
| 0.75293
| 3
| 0
| 0
|
no
| 0.92
| 0.9
|
no dnr
| 21
| 77
| 20.296875
| 142
| 10
| 39.09375
| 168
| 2.699707
| null | 0.799927
| 135
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,927
| 0
|
65.04596
|
female
| 1
| 30
|
MOSF w/Malig
|
ARF/MOSF
| 0
| null |
under $11k
| 100
| 87,928.938
| 61,871.6562
| null | 28.5
|
black
| 18.296875
| 8
| 0.27594
| 0.167999
| 12
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 19
| 93
| 11.398438
| 106
| 11
| 38.5
| 406.625
| 2.599609
| 0.5
| 1
| 133
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 30
| 1
|
72.29297
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 5
| null | null | 44
| 1,849.149
| 1,677.3008
| null | 9
|
white
| 23.597656
| 37
| 0.303955
| 0.051994
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 70
| 5.5
| 64
| 36
| 36.39844
| 335
| null | null | 3.099609
| 142
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.919434
| 4
| 1
|
50.30298
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$25-$50k
| 0
| null | null | null | 9
|
white
| 21.597656
| 21
| 0.904907
| 0.840942
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 1
| 108
| 9.5
| 115
| 24
| 35.39844
| 285.6875
| null | 0.299988
| 0.799927
| 142
| 7.339844
| null | null | null | 5
| 5
|
SIP>=30
| 5
| 373
| 1
|
27.55899
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 54,286.625
| 39,041
| null | 32.666657
|
white
| 23.398438
| 55
| 0.905884
| 0.872925
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 24
| 70
| 9.5
| 110
| 23
| 36.5
| 280
| 2.099609
| 0.599976
| 7.699219
| 146
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,922
| 0
|
66.31598
|
male
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 7
|
$11-$25k
| 0
| 27,578.297
| 19,002.8281
| null | 14
|
white
| 19.699219
| 24
| 0.860962
| 0.769897
| 1
| 1
| 0
|
no
| 0.95
| 0.93
|
no dnr
| 18
| 80
| 12.199219
| 100
| 24
| 37.29688
| null | 3.399902
| null | 1.599854
| 136
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 397
| 1
|
38.74298
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 26
| 121,979.062
| 81,317.4375
| null | 51.5
|
white
| 47.09375
| 69
| 0.215973
| 0.118988
| 6
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 7
| 93
| 12.298828
| 112
| 12
| 35.59375
| 144.875
| 4.099609
| 29.199219
| 3.699707
| 142
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
82.89697
|
male
| 1
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 3
|
under $11k
| 55
| 37,978.875
| 25,475.9688
| null | 53
|
black
| 38.296875
| 53
| 0.071991
| 0.009998
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 4
| 63
| 18
| 150
| 26
| 37.5
| 135
| 1.599854
| 0.199982
| 1.099854
| 136
| 7.319336
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 13
| 1
|
60.84299
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
$11-$25k
| 9
| 31,849.109
| 23,183.5156
| null | 21.333328
|
white
| 23.5
| 31
| 0.805908
| 0.740967
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 15
| 108
| 20.097656
| 110
| 34
| 38.39844
| 168.5625
| null | 0.599976
| 1
| 146
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.939941
| 1,920
| 0
|
59.48297
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 10,657.312
| 8,153.3203
| null | 12.666664
|
white
| 18
| 12
| 0.700928
| 0.41394
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 14
| 80
| 11.898438
| 100
| 20
| 38.59375
| 304.75
| null | null | 0.699951
| 135
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 137
| 1
|
66.00397
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 21
|
>$50k
| 0
| null | null | null | 19
|
white
| 24.296875
| 20
| 0.690918
| 0.40094
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.4
|
no dnr
| 6
| 93
| 6.899414
| 70
| 16
| 36.19531
| null | 2.799805
| 0.399963
| 1.5
| 135
| null | null | null | null | 4
| 4
|
<2 mo. follow-up
| 4
| 57
| 1
|
55.90698
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 2,410.699
| 1,712.7959
| null | 3
|
white
| 17.398438
| 25
| 0.720947
| 0.444946
| 1
| 1
| 0
|
metastatic
| 0.95
| 0.6
|
no dnr
| 3
| 113
| 7.199219
| 80
| 22
| 35.89844
| null | null | null | 1.599854
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.216309
| 134
| 1
|
83.92596
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 22,317.844
| 12,897.8828
| null | 25
|
white
| 19.898438
| 31
| 0.751953
| 0.60791
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 6
| 99
| 11
| 68
| 20
| 36.79688
| 342.8125
| null | null | 2.299805
| 139
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,868
| 1
|
78.11395
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
|
$11-$25k
| 0
| 67,608.5
| 43,753.75
| null | 44
|
white
| 37.09375
| 57
| 0.273987
| 0.165985
| 7
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 5
| 43
| 8.898438
| 124
| 25
| 39
| 122.84375
| 2
| null | 1.099854
| 147
| 7.489258
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 10
| 1
|
58.09698
|
male
| 1
| 10
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 9,295.594
| 6,644.8711
| null | 9.5
|
white
| 29.597656
| 13
| 0.408997
| 0.108994
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
dnr after sadm
| 10
| 90
| 7.899414
| 120
| 24
| 36.79688
| null | 2.599609
| 1.299805
| 0.799927
| 139
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.260742
| 10
| 1
|
73.04596
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
$11-$25k
| 0
| 99,060.062
| 63,955.4375
| null | 53.333313
|
black
| 16.5
| 43
| 0.835938
| 0.779907
| 9
| 1
| 1
|
no
| 0.5
| 0.5
|
no dnr
| 18
| 67
| 6.399414
| 68
| 10
| 38.29688
| 533.25
| 1.199951
| 0.299988
| 2.099609
| 141
| 7.419922
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 18
| 1
|
69.15295
|
female
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 100
| 272,269.5
| 173,140.875
| null | 52.75
|
white
| 28.796875
| 61
| 0.125977
| 0.056
| 32
| 0
| 0
|
no
| null | null |
no dnr
| 28
| 87
| 9.298828
| 100
| 50
| 38.5
| 165
| 4.699219
| 3.099609
| 2
| 140
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 4.070313
| 28
| 1
|
65.52496
|
female
| 1
| 18
|
Coma
|
Coma
| 0
| 16
|
$25-$50k
| 100
| 16,579.594
| 12,479.7266
| null | 14
|
black
| 22.597656
| 34
| 0.23999
| 0.173981
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 62
| 14.599609
| 64
| 28
| 35.29688
| 476.625
| null | 1
| 1.5
| 136
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.305664
| 18
| 1
|
76.77997
|
male
| 1
| 110
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
under $11k
| 0
| 419,652.25
| 280,731
| null | 46.75
|
white
| 26.5
| 54
| 0.633911
| 0.531982
| 15
| 0
| 0
|
no
| null | null |
no dnr
| 110
| 59
| 7
| 142
| 8
| 35.69531
| 226.65625
| 2.799805
| null | 1.899902
| 134
| 7.379883
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 110
| 1
|
37.74698
|
female
| 1
| 56
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 75,506.125
| 54,050.4688
| null | 22.5
|
black
| 23.597656
| 22
| 0.779907
| 0.707886
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 55
| 63
| 4.299805
| 130
| 10
| 39.29688
| 544
| 2.699707
| 0.099991
| 0.699951
| 135
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.404297
| 56
| 1
|
57.57397
|
male
| 1
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 13,889.844
| 10,675
| null | 30
|
white
| 27.097656
| 30
| 0.79895
| 0.675903
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 5
| 74
| 6.199219
| 108
| 14
| 35
| 264
| 2.899902
| 0.699951
| 1.599854
| 135
| 7.469727
| null | null | null | 2
| 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
53.07898
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
$11-$25k
| 0
| 59,744.844
| 40,375.875
| null | 19.25
|
white
| 20.097656
| 19
| 0.795898
| 0.728882
| 3
| 0
| 0
|
metastatic
| 0.9
| 0.85
|
no dnr
| 38
| 83
| 9.199219
| 135
| 8
| 37.29688
| 323.3125
| 2.399902
| null | 1
| 132
| 7.40918
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,915
| 0
|
62.03998
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 2
| 9
|
$25-$50k
| 0
| 28,018.188
| 18,572.7344
| null | 21
|
white
| 44.296875
| 43
| 0.046997
| 0.001
| 1
| 0
| 0
|
metastatic
| 0.5
| 0
|
no dnr
| 15
| 112
| 29.597656
| 130
| 36
| 35.79688
| 152.5
| 2.399902
| 0.299988
| 0.599976
| 140
| 7.389648
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
66.46698
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 100
| 35,396.781
| 21,861.125
| null | 45
|
black
| 36.296875
| 59
| 0.050995
| 0.015999
| 4
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 45
| 10.599609
| 140
| 36
| 38.59375
| 172.5
| null | null | 1.5
| 143
| 7.319336
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
55.85498
|
male
| 1
| 24
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 19,714.938
| 15,110.1172
| null | 10
|
white
| 39.59375
| 45
| 0.312988
| 0.131989
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 14
| 90
| 11.199219
| 94
| 18
| 34.39844
| null | 2.799805
| 33
| 1.399902
| 126
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.322754
| 24
| 1
|
65.81195
|
male
| 0
| 26
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 9
| null | 0
| 47,714.625
| 33,123.1562
| null | 25.25
|
white
| 21.296875
| 40
| 0.844971
| 0.744995
| 1
| 1
| 0
|
no
| 0.2
| 0.008
|
no dnr
| 26
| 75
| 8.5
| 110
| 26
| 37.19531
| 312
| null | 0.799927
| 1.699951
| 135
| 7.429688
| null | null | null | 0
| 7
|
<2 mo. follow-up
| 7
| 51
| 1
|
26.834
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 16,465.844
| 11,702.9375
| null | 14
|
black
| 34.898438
| 66
| 0.764893
| 0.689941
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 11
| 136
| 16.898438
| 0
| 0
| 35.89844
| 336
| null | 1.299805
| 5.899414
| 139
| 7.329102
| null | null | null | 0
| 2
| null | 2
| 1,911
| 0
|
69.11395
|
male
| 1
| 15
|
Coma
|
Coma
| 2
| null |
under $11k
| 100
| 45,662.281
| 31,362.1875
| null | 27
|
black
| 19.398438
| 33
| 0.223999
| 0.16098
| 5
| 1
| 0
|
no
| null | null |
dnr after sadm
| 12
| 123
| 12.099609
| 94
| 35
| 38.09375
| 456.625
| null | null | 1.699951
| 139
| 7.649414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
49.71698
|
male
| 1
| 103
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 345,511.75
| 221,787.375
| null | 50
|
white
| 33.898438
| 47
| 0.699951
| 0.609985
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 18
| 83
| 11.599609
| 140
| 36
| 39
| 73.32812
| 2
| 0.199982
| 0.599976
| 147
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 103
| 1
|
43.03897
|
male
| 0
| 18
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 25,087.047
| 17,921
| null | 12.333328
|
white
| 17.398438
| 22
| 0.75
| 0.48999
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 18
| 100
| 9.599609
| 140
| 18
| 37.29688
| null | 3.599609
| 0.299988
| 1.099854
| 142
| null | null | null | null | 1
| 1
|
adl>=4 (>=5 if sur)
| 1
| 128
| 1
|
67.85498
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 29,172.891
| 18,237.5938
| null | 45
|
white
| 42.796875
| 57
| 0.314941
| 0.132996
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 46
| 14.099609
| 62
| 24
| 36.69531
| 160
| null | null | 4
| 124
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
76.59698
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
| null | 0
| 68,324.75
| 45,443.0938
| null | 30.5
|
white
| 17.597656
| 28
| 0.809937
| 0.746948
| 10
| 1
| 0
|
no
| 0.3
| 0.2
|
no dnr
| 9
| 65
| 8
| 58
| 9
| 37.29688
| 242.84375
| null | null | 2
| 142
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
54.409
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 41
| 28,525.047
| 19,878.1094
| null | 31
|
white
| 32.398438
| 56
| 0.47699
| 0.358948
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 103
| 29.097656
| 140
| 24
| 37.59375
| 160
| null | 1.399902
| 2.799805
| 133
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.597168
| 5
| 1
|
71.82996
|
male
| 0
| 44
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 110,116.562
| 70,567.125
| null | 20.5
|
black
| 19.796875
| 22
| 0.830933
| 0.724976
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 44
| 86
| 15.298828
| 72
| 18
| 37
| null | null | null | 1.799805
| 132
| null | null | null | null | 0
| 1
| null | 1
| 1,106
| 1
|
71.91797
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 61
| 84,830.938
| 58,373.6875
| null | 26.5
|
white
| 21.5
| 25
| 0.557983
| 0.444946
| 5
| 0
| 0
|
no
| null | null |
dnr after sadm
| 16
| 57
| 5.699219
| 110
| 8
| 38.59375
| 500
| null | null | 0.899902
| 134
| 7.389648
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,127
| 1
|
85.57996
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 0
| null | null | null | 37
|
white
| 21.699219
| 42
| 0.751953
| 0.67395
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 60
| 23.5
| 62
| 18
| 37.09375
| 149
| 2.299805
| 0.699951
| 1.199951
| 135
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
61.92697
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 0
| 17,596.484
| 12,805.6875
| null | 22
|
black
| 17.398438
| 30
| 0.899902
| 0.831909
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 9
| 83
| 2
| 80
| 33
| 36.69531
| 216.65625
| null | 0.5
| 1.699951
| 141
| 7.449219
| null | null | null | 1
| 1
| null | 1
| 432
| 1
|
21.405
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
$11-$25k
| 0
| null | null | null | 5
|
white
| 20.097656
| 14
| 0.944946
| 0.904907
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 12
| 65
| 10.898438
| 118
| 20
| 36.5
| null | null | null | 1.099854
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,906
| 0
|
62.83899
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 3
|
under $11k
| 0
| 15,547.047
| 11,720.3203
| null | 13
|
black
| 21.796875
| 36
| 0.855957
| 0.761963
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 100
| 10.599609
| 92
| 16
| 36.59375
| 252
| 3.299805
| 0.099991
| 7.099609
| 136
| 7.219727
| null | null | null | null | 0
|
SIP>=30
| 0
| 167
| 1
|
62.004
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 18,162.547
| 13,435.8047
| null | 10
|
black
| 16.898438
| 15
| 0.892944
| 0.85498
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 14
| 77
| 14.898438
| 90
| 24
| 36.29688
| 321.6875
| null | 0.299988
| 0.899902
| 140
| 7.359375
| null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 1,123
| 1
|
59.29599
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| null | null | null | 11
|
white
| 15.898438
| 13
| 0.840942
| 0.650879
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 100
| 7.599609
| 96
| 20
| 36.79688
| null | 3.599609
| 0.699951
| 0.599976
| 137
| null | null | null | null | null | null | null | 1.702393
| 65
| 1
|
78.84698
|
male
| 1
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 4,319.68
| 3,077.4668
| null | 12
|
black
| 18.898438
| 26
| 0.831909
| 0.724976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 62
| 4.5
| 78
| 20
| 35.59375
| 338.0625
| null | null | 1.799805
| 141
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.180176
| 5
| 1
|
65.83997
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 61
| 96,527.75
| 61,453.4062
| null | 51.333313
|
white
| 40.195313
| 68
| 0.068985
| 0.024998
| 2
| 0
| 0
|
yes
| 0.2
| 0.18
|
dnr after sadm
| 16
| 48
| 6.799805
| 110
| 29
| 38.5
| 138
| 2.599609
| 5.099609
| 2.699707
| 137
| 7.359375
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 16
| 1
|
66.38995
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 14,528.797
| 10,640.1562
| null | 9.5
|
black
| 16.398438
| 12
| 0.879883
| 0.836914
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 99
| 8.798828
| 62
| 15
| 36.89844
| 319
| null | null | 0.599976
| 140
| 7.419922
| null | null | null | null | null | null | 2.377441
| 1,091
| 1
|
79.34296
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 33,593.688
| 23,662.5469
| null | 25
|
white
| 25.597656
| 35
| 0.705933
| 0.544922
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 66
| 6.399414
| 120
| 8
| 35.79688
| 392.5
| null | null | 2.099609
| 134
| 7.419922
| null | null | null | null | 0
| null | 0
| 1,895
| 0
|
67.95898
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 4
|
under $11k
| 0
| 2,900.449
| 2,445.7988
| null | 11
|
black
| 14.5
| 18
| 0.902954
| 0.837891
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 82
| 7.599609
| 80
| 16
| 36.29688
| 290.4375
| null | null | 1.199951
| 139
| 7.5
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,186
| 1
|
66.20697
|
female
| 1
| 4
|
Colon Cancer
|
Cancer
| 1
| 4
|
under $11k
| 0
| 4,139.977
| 3,156.7598
| null | 21
|
black
| 36.09375
| 51
| 0.379944
| 0.090988
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 4
| 93
| 35
| 96
| 28
| 35.79688
| null | null | 6.599609
| 2.199707
| 128
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 4
| 1
|
63.168
|
male
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 24,771.141
| 17,050.9844
| null | 16
|
hispanic
| 21.898438
| 21
| 0.815918
| 0.701904
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 19
| 97
| 11.599609
| 106
| 26
| 37.69531
| 240
| 3.199707
| 0.799927
| 0.899902
| 133
| 7.399414
| null | null | null | 3
| 5
|
SIP>=30
| 5
| 1,895
| 0
|
71.48798
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 5,364.898
| 4,105.3789
| null | 10
|
white
| 12.898438
| 14
| 0.907959
| 0.845947
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 8
| 83
| 7.099609
| 54
| 16
| 36.59375
| null | 4
| 0.699951
| 1
| 139
| null | null | null | null | 2
| 5
|
SIP>=30
| 5
| 1,202
| 1
|
59.58398
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 6,601.348
| 4,765.2305
| null | 8
|
white
| 13.898438
| 9
| 0.862915
| 0.692993
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 87
| 8.599609
| 80
| 20
| 37.69531
| null | null | null | 0.699951
| 142
| null | null | null | null | null | null | null | 1.652344
| 493
| 1
|
68.39197
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 9
| 38,632.281
| 26,844.7188
| null | 23
|
white
| 17.296875
| 15
| 0.803955
| 0.738892
| 30
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 112
| 12.398438
| 98
| 16
| 37.39844
| 334.75
| null | 1.299805
| 1.099854
| 138
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,892
| 0
|
31.83299
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 24,312.484
| 18,691.125
| null | 18.5
|
black
| 19.699219
| 32
| 0.916992
| 0.886963
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 11
| 75
| 10.5
| 78
| 25
| 38.59375
| 272
| 2.5
| 5.699219
| 0.899902
| 140
| 7.389648
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 1,892
| 0
|
50.23398
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 58,971.531
| 38,017.8438
| null | 48.5
|
white
| 22.796875
| 30
| 0.846924
| 0.793945
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 12
| 68
| 9.798828
| 120
| 12
| 39.09375
| 254.28125
| null | null | 1.799805
| 134
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,891
| 0
|
70.29199
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
| null | 44
| 73,765.25
| 50,947.5625
| null | 43
|
black
| 24.796875
| 48
| 0.557983
| 0.445984
| 5
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 22
| 69
| 5.599609
| 114
| 16
| 38.5
| 148
| null | null | 13.798828
| 139
| 7.389648
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 23
| 1
|
55.62799
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$11-$25k
| 0
| 71,645.5
| 47,409.7812
| null | 38.666657
|
white
| 27.398438
| 30
| 0.774902
| 0.701904
| 2
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 23
| 63
| 11.599609
| 110
| 12
| 38.5
| 145
| 2.699707
| null | 1.199951
| 128
| 7.439453
| null | null | null | null | 0
| null | 0
| 60
| 1
|
52.293
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 8,464.25
| 6,247.8789
| null | 5
|
black
| 15.898438
| 8
| 0.922974
| 0.868896
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 8
| 90
| 6.599609
| 88
| 20
| 35.79688
| null | 3.599609
| 1.299805
| 1
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,887
| 0
|
54.78998
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 5,985.949
| 4,069.2969
| null | 5
|
black
| 15.898438
| 3
| 0.918945
| 0.861938
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 90
| 3.799805
| 94
| 20
| 36.29688
| 320
| null | 0.799927
| 1
| 136
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,887
| 0
|
60.69498
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 5
|
under $11k
| 0
| 32,884.094
| 22,593.8594
| null | 37.5
|
black
| 25.898438
| 34
| 0.61792
| 0.512939
| 8
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 13
| 91
| 15.199219
| 114
| 8
| 36.39844
| 305.6875
| null | 1.699951
| 2.099609
| 136
| 7.529297
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 470
| 1
|
80.52594
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 6,475.199
| 4,829.2969
| null | 14
|
black
| 27.699219
| 36
| 0.674927
| 0.503906
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 79
| 7.899414
| 76
| 25
| 36.29688
| 85
| null | 0.5
| 1.899902
| 135
| 7.319336
| null | null | null | null | null | null | 2.589356
| 1,887
| 0
|
71.15094
|
male
| 1
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
| null | 26
| 137,788.75
| 93,939.75
| null | 39.25
|
black
| 19.296875
| 39
| 0.786987
| 0.717896
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 42
| 93
| 7.199219
| 78
| 8
| 35.69531
| 265.6875
| 2.799805
| 0.299988
| 9.699219
| 146
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.165527
| 49
| 1
|
39.84097
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 10
|
$11-$25k
| 0
| 31,942.234
| 21,611.3281
| null | 46.5
|
black
| 25.699219
| 42
| 0.814941
| 0.700928
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 8
| 92
| 4.299805
| 110
| 14
| 36.69531
| 207.5
| 1.799805
| 4.799805
| 1.799805
| 134
| 7.399414
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
51.61099
|
female
| 1
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 136,609.375
| 93,343.875
| null | 42.5
|
white
| 31.898438
| 48
| 0.72998
| 0.645996
| 1
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 30
| 86
| 22.898438
| 112
| 30
| 36.59375
| 160
| null | 1.299805
| 6.099609
| 141
| 7.299805
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 44
| 1
|
63.431
|
female
| 0
| 60
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 150,283.625
| 100,000.75
| null | 36.75
|
white
| 32
| 54
| 0.670898
| 0.574951
| 1
| 0
| 0
|
no
| 0.95
| 0.92
|
no dnr
| 60
| 67
| 13.5
| 188
| 25
| 39.09375
| 76
| null | 0.799927
| 1.299805
| 143
| 7.449219
| null | null | null | null | null | null | 2.333008
| 1,883
| 0
|
68.64899
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 21,254.391
| 15,073.5391
| null | 28
|
white
| 25.097656
| 39
| 0.748901
| 0.603882
| 4
| 1
| 0
|
no
| 0.6
| 0.45
|
no dnr
| 13
| 70
| 8.699219
| 110
| 10
| 35.5
| 430
| null | null | 1.299805
| 131
| 7.5
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 82
| 1
|
38.18198
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 3,886.5
| 2,888.7129
| null | 12
|
white
| 20.699219
| 12
| 0.816895
| 0.605957
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 91
| 9.599609
| 126
| 16
| 38.59375
| null | null | 0.699951
| 0.5
| 137
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 100
| 1
|
73.41296
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 44
| 57,947.938
| 39,225.5938
| null | 50
|
black
| 43.898438
| 73
| 0.059998
| 0.019997
| 4
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 8
| 111
| 9.5
| 102
| 13
| 35.79688
| 153.3125
| 2.699707
| 12.599609
| 4.199219
| 126
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.482422
| 10
| 1
|
56.45999
|
male
| 0
| 117
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 253,438.625
| 175,935.75
| null | 34
|
white
| 27.398438
| 59
| 0.559937
| 0.44696
| 8
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 117
| 67
| 16.097656
| 110
| 36
| 38.59375
| 230
| 2.599609
| 2.599609
| 8.5
| 134
| 7.319336
| null | null | null | null | null | null | 2.549316
| 1,882
| 0
|
62.75998
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 6,991.598
| 4,942.6133
| null | 8
|
white
| 17.898438
| 11
| 0.80896
| 0.591919
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 8
| 90
| 11.599609
| 78
| 18
| 35.59375
| null | null | 0.899902
| 0.799927
| 140
| null | null | null | null | 0
| 0
| null | 0
| 127
| 1
|
71.62195
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,631.492
| 9,751.5312
| null | 2.333332
|
black
| 22.597656
| 33
| 0.807983
| 0.689941
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 110
| 3.799805
| 76
| 20
| 35.5
| null | null | 0.799927
| 3.399902
| 139
| null | null | null | null | null | null | null | 2.90918
| 78
| 1
|
83.61096
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 4,798.297
| 4,055.584
| null | 8
|
black
| 23.296875
| 42
| 0.745972
| 0.599976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 67
| 7.5
| 64
| 28
| 37.29688
| null | null | 1.099854
| 2.899902
| 132
| null | null | null | null | null | null | null | 3.824219
| 1,230
| 1
|
83.32397
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 23
|
$11-$25k
| 0
| 22,936.141
| 16,438.5312
| null | 21
|
white
| 29.097656
| 31
| 0.497986
| 0.379944
| 4
| 0
| 1
|
yes
| null | null |
dnr after sadm
| 3
| 90
| 15.5
| 118
| 24
| 35.59375
| 282.5625
| 2.5
| 3.599609
| 0.699951
| 131
| 7.449219
| null | null | null | 2
| 1
|
SIP>=30
| 1
| 480
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.